Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LEO 158968
- Development stage
- Phase 1
- Lead developer
- LEO Pharma
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intravenous, Subcutaneous
01
Overview
LEO 158968 is a monoclonal antibody developed by LEO Pharma for the treatment of inflammatory diseases, including anti-inflammatory skin disorders and gout flares. It is administered via intravenous or subcutaneous injection. The drug is designed to block signaling pathways of three interleukin-1 (IL-1) family members, which play important roles in inflammatory and immune responses. As a new molecular entity, its precise mechanism of action has not been fully defined but it targets key mediators involved in inflammation. Clinical development has reached Phase 1 trials for pain, skin disorders, and gout flares[1][2][6][7].
- Other names
- anti-interleukin-1 receptor accessory protein antibodyanti-interleukin1 receptor accessory protein antibodyanti-interleukin 1 receptor accessory protein antibodyanti-IL-1RAcP antibodyanti-IL1RAcP antibodyanti-IL 1RAcP antibody
02
Targets
IL1RAP (Interleukin 1 receptor accessory protein)
Beyond the preview
Go deeper on LEO 158968.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LEO 158968.